NO971196L - Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid - Google Patents
Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamidInfo
- Publication number
- NO971196L NO971196L NO971196A NO971196A NO971196L NO 971196 L NO971196 L NO 971196L NO 971196 A NO971196 A NO 971196A NO 971196 A NO971196 A NO 971196A NO 971196 L NO971196 L NO 971196L
- Authority
- NO
- Norway
- Prior art keywords
- androst
- phenylprop
- aza
- carboxamide
- trifluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95MI001587A IT1275594B1 (it) | 1995-07-21 | 1995-07-21 | Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide |
PCT/EP1996/002830 WO1997004002A1 (en) | 1995-07-21 | 1996-06-28 | EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5α-ANDROST-1-ENE-17β-CARBOXAMIDE |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971196D0 NO971196D0 (no) | 1997-03-14 |
NO971196L true NO971196L (no) | 1997-03-14 |
Family
ID=11372032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971196A NO971196L (no) | 1995-07-21 | 1997-03-14 | Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0782582A1 (ko) |
JP (1) | JPH10506411A (ko) |
KR (1) | KR970706298A (ko) |
CN (1) | CN1159195A (ko) |
AR (1) | AR003967A1 (ko) |
AU (1) | AU6418396A (ko) |
BR (1) | BR9606527A (ko) |
CA (1) | CA2199273A1 (ko) |
EA (1) | EA199700045A1 (ko) |
HU (1) | HUP9702465A3 (ko) |
IL (1) | IL120343A0 (ko) |
IT (1) | IT1275594B1 (ko) |
MX (1) | MX9701948A (ko) |
NO (1) | NO971196L (ko) |
PL (1) | PL319351A1 (ko) |
WO (1) | WO1997004002A1 (ko) |
ZA (1) | ZA965678B (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000013509A1 (en) * | 1998-09-09 | 2000-03-16 | Merck & Co., Inc. | Method of determining and reducing the risk of bph-related urologic events |
EP1146873B1 (en) * | 1999-01-25 | 2005-03-16 | Smithkline Beecham Corporation | Anti-androgens and methods for treating disease |
CN100355772C (zh) * | 2005-12-28 | 2007-12-19 | 天津大学 | 具有5α-还原酶抑制活性的甾体化合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9216284D0 (en) * | 1992-07-31 | 1992-09-16 | Erba Carlo Spa | Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives |
-
1995
- 1995-07-21 IT IT95MI001587A patent/IT1275594B1/it active IP Right Grant
-
1996
- 1996-06-28 MX MX9701948A patent/MX9701948A/es unknown
- 1996-06-28 CA CA002199273A patent/CA2199273A1/en not_active Abandoned
- 1996-06-28 JP JP9506217A patent/JPH10506411A/ja active Pending
- 1996-06-28 PL PL96319351A patent/PL319351A1/xx unknown
- 1996-06-28 HU HU9702465A patent/HUP9702465A3/hu unknown
- 1996-06-28 WO PCT/EP1996/002830 patent/WO1997004002A1/en not_active Application Discontinuation
- 1996-06-28 KR KR1019970701797A patent/KR970706298A/ko not_active Application Discontinuation
- 1996-06-28 CN CN96190785A patent/CN1159195A/zh active Pending
- 1996-06-28 IL IL12034396A patent/IL120343A0/xx unknown
- 1996-06-28 BR BR9606527A patent/BR9606527A/pt not_active Application Discontinuation
- 1996-06-28 EP EP96923968A patent/EP0782582A1/en not_active Withdrawn
- 1996-06-28 AU AU64183/96A patent/AU6418396A/en not_active Abandoned
- 1996-07-04 ZA ZA965678A patent/ZA965678B/xx unknown
- 1996-07-19 AR ARP960103652A patent/AR003967A1/es unknown
-
1997
- 1997-03-14 NO NO971196A patent/NO971196L/no unknown
- 1997-04-18 EA EA199700045A patent/EA199700045A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
ITMI951587A1 (it) | 1997-01-21 |
NO971196D0 (no) | 1997-03-14 |
CA2199273A1 (en) | 1997-02-06 |
ITMI951587A0 (it) | 1995-07-21 |
IL120343A0 (en) | 1997-06-10 |
BR9606527A (pt) | 1997-12-23 |
PL319351A1 (en) | 1997-08-04 |
ZA965678B (en) | 1997-01-24 |
HUP9702465A2 (hu) | 1998-05-28 |
AU6418396A (en) | 1997-02-18 |
JPH10506411A (ja) | 1998-06-23 |
MX9701948A (es) | 1997-06-28 |
CN1159195A (zh) | 1997-09-10 |
HUP9702465A3 (en) | 1998-11-30 |
IT1275594B1 (it) | 1997-08-06 |
EA199700045A1 (ru) | 1997-12-30 |
EP0782582A1 (en) | 1997-07-09 |
AR003967A1 (es) | 1998-09-30 |
WO1997004002A1 (en) | 1997-02-06 |
KR970706298A (ko) | 1997-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE255589T1 (de) | Kristallin form i von clarithromycin | |
NO2005025I1 (no) | Krystalinsk ceftiofurfri syre, fremgangsmate for fremstilling av denne, og farmasoytisk preparat | |
DK0982032T3 (da) | Anvendelse af en sulfamatesterholdig sterolforbindelse til fremstilling af et lægemiddel til kontrol af østrogenproduktion | |
NO20015601L (no) | Enzym-instantformuleringer av enzymer for dyrefôr | |
NO20022558L (no) | 4-karboksyamino-2-etyl-1,2,3,4-tetrahydrokinolinkrystall som CETP inhibitor | |
TR199901578T2 (xx) | Klaritromisin form 0 kristali | |
NO20003514L (no) | Hypolipidemiske benzothiazepin-forbindelser | |
AU3631197A (en) | N-benzylpiperidine and tetrahydropyridine derivatives | |
NO963370D0 (no) | Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE | |
BR9907788A (pt) | Agentes antiinflamatórios seletivos paraglicocorticóides | |
NO991494D0 (no) | <beta>-sulfonylhydroksaminsyrer som matriksmetalloproteinaseinhibitorer | |
NO20002676D0 (no) | Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme | |
NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
NO986049L (no) | Matrise metallproteinaseinhibitorer | |
CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
AU4765796A (en) | Imidazolidinone derivatives as corrosion inhibitors | |
AU7675896A (en) | Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents | |
NO971196L (no) | Epimerer av (22RS)-N-(1,1,1-trifluor-2-fenylprop-2-yl)-3-okso-4-aza-5<alfa>-androst-1-en-17<beta>-karboksamid | |
WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
NO943765L (no) | Aryloksybenzen-herbicidmidler | |
IL77051A (en) | Crystalline form of the monoethanolamine salt of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide 1,1-dioxide and pharmaceutical compositions containing it | |
TW344650B (en) | Fungicidal compositions and the process for the preparation thereof | |
NZ502537A (en) | Androst-1-en-3-one derivatives and pharmaceutical formulations thereof; useful for the treatment of alopecia, female hirsutism, seborrhea, and useful for the prevention of bone metastasis caused by prostatic cancer | |
AU1200097A (en) | 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them | |
NZ237559A (en) | Halogenoethyl steroid derivatives and pharmaceutical compositions |